CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing mesoporous silica nanoparticles that can function as both diagnostic and therapeutic agents in the body. The goal is to create nanoparticles that can safely degrade into smaller, easily excreted components after completing their medical tasks, enhancing their clinical usability.
Despite their great potential, full exploitation of mesoporous silica nanoparticles (MSiNPs) as in-vivo multi-functional theranostic agents is still held back by the lack of a controlled and complete biodegradability.
Indeed removal of nano-medical tools from the biologic system after the accomplishment of their diagnostic or therapeutic function still remains a pivotal, yet unresolved issue impeding their clinical translation. A most desirable design for improving the properties of nano-medical…
UNIVERSITE DE STRASBOURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
